A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma
Author:
Funder
Department of Health’s NIHR Biomedical Research Centres
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference55 articles.
1. Ten challenges in the management of neuroblastoma;Gains;Future Oncol,2012
2. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment;Brodeur;J Clin Oncol,1993
3. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma;Brodeur;J Clin Oncol,1988
4. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project;Moroz;Eur J Cancer,2011
5. Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma;Gaze;Q J Nucl Med Mol Imaging,2013
Cited by 125 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report;Frontiers in Oncology;2024-09-11
2. Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma;EJNMMI Research;2024-06-13
3. A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma;EJC Paediatric Oncology;2024-06
4. Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics;Analytical Sciences;2024-04-02
5. Visual conservation treatment dilemmas in neuroblastoma with bilateral blindness;Discover Oncology;2024-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3